Research keywords (5)：
Primary Sclerosing Cholangitis
, Primary Biliary Cirrhosis
, Liver Transplantation
, Liver Cancer
, Viral Hepatitis
Research theme for competitive and other funds (2)：
2006 - 抗薬剤耐性アンチセンス遺伝子による肝細胞癌の治療法の開発
2004 - 難治性の肝・胆道疾患に関する調査研究
Papers (241)：
Yokoyama K, Irie M, Tsuchiya N, Yamauchi E, Kawashima M, Miyayama T, Fukuda H, Yamauchi R, Umeda K, Takata K, et al. Irsogladine maleate alters expression of a tight junction protein in portal hypertensive gastropathy. J Gastroenterol Hepatol. 2020
Kunimoto H, Shakado S, Tanaka T, Takata K, Yamauchi R, Fukuda H, Tsuchiya N, Yokoyama K, Morihara D, Takeyama Y, et al. Reduction in Tumor Stain at 2 Weeks after Treatment Initiation Is a Predictor of the Efficacy of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma. Oncology. 2020. 2. 1-8
Tanaka T, Takata K, Kunimoto H, Fukuda H, Yamauchi R, Tsuchiya N, Inomata S, Yokoyama K, Morihara D, Takeyama Y, et al. The Efficacy and Therapeutic Outcome of Bipolar Radiofrequency Ablation for the Treatment for Hepatocellular Carcinoma in the Real-World Setting, Compared with Monopolar Radiofrequency Ablation Conducted during the Same Period. Oncology. 2020. 14. 1-10
Hideto Sakisaka, Hidetoshi Takedatsu, Keiichi Mitsuyama, Shinichi Mochizuki, Kazuo Sakurai, Shotaro Sakisaka, Fumihito Hirai. Topical Therapy with Antisense Tumor Necrosis Factor Alpha Using Novel -Glucan-Based Drug Delivery System Ameliorates Intestinal Inflammation. International Journal of Molecular Sciences. 2020. 20;21. 2. pii: E683.
Yokoyama K, Tsuchiya N, Yamauchi R, Miyayama T, Uchida Y, Shibata K, Fukuda H, Umeda K, Takata K, Tanaka T, et al. Exploratory Research on the Relationship between Human Gut Microbiota and Portal Hypertension. Intern Med. 2020. 59. 17. 2089-2094
Synergistic effect of clostridium butyricum miyairi on rifaximin in mice model of non-alcoholic steatohepatitis by methionine choline-deficient diet
(THE DIGITAL INTERNATIONAL LIVER CONGRESS European Association for the Study of the Liver(EASL) 2020)
